Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500114230Phase 4Not yet recruiting
Phase 4 trial of metahydroxylamine in hypotension (4 arms), sponsored by Wenzhou Hospital of Traditional Chinese and Western Medicine. Primary endpoint: Incidence of hypotension. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500114230.